159 related articles for article (PubMed ID: 12493767)
1. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy.
Wang L; Saada A; Eriksson S
J Biol Chem; 2003 Feb; 278(9):6963-8. PubMed ID: 12493767
[TBL] [Abstract][Full Text] [Related]
2. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria.
Wang L; Eriksson S
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):469-76. PubMed ID: 11023833
[TBL] [Abstract][Full Text] [Related]
4. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
[TBL] [Abstract][Full Text] [Related]
7. Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future.
Pérez-Pérez MJ; Priego EM; Hernández AI; Familiar O; Camarasa MJ; Negri A; Gago F; Balzarini J
Med Res Rev; 2008 Sep; 28(5):797-820. PubMed ID: 18459168
[TBL] [Abstract][Full Text] [Related]
8. Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.
Blázquez-Bermejo C; Molina-Granada D; Vila-Julià F; Jiménez-Heis D; Zhou X; Torres-Torronteras J; Karlsson A; Martí R; Cámara Y
EBioMedicine; 2019 Aug; 46():342-355. PubMed ID: 31351931
[TBL] [Abstract][Full Text] [Related]
9. Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion.
Zhang S; Li FY; Bass HN; Pursley A; Schmitt ES; Brown BL; Brundage EK; Mardach R; Wong LJ
Mol Genet Metab; 2010 Jan; 99(1):53-7. PubMed ID: 19815440
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency.
Lopez-Gomez C; Sanchez-Quintero MJ; Lee EJ; Kleiner G; Tadesse S; Xie J; Akman HO; Gao G; Hirano M
Ann Neurol; 2021 Oct; 90(4):640-652. PubMed ID: 34338329
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
[TBL] [Abstract][Full Text] [Related]
13. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs.
Wang L; Sun R; Eriksson S
Antimicrob Agents Chemother; 2011 Jun; 55(6):2552-8. PubMed ID: 21444706
[TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.
Sun R; Wang L
Biochemistry; 2014 Oct; 53(39):6142-50. PubMed ID: 25215937
[TBL] [Abstract][Full Text] [Related]
15. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.
Leshinsky-Silver E; Michelson M; Cohen S; Ginsberg M; Sadeh M; Barash V; Lerman-Sagie T; Lev D
Eur J Paediatr Neurol; 2008 Jul; 12(4):309-13. PubMed ID: 17951082
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-targeted transgenic mutant mitochondrial enzymes: mtDNA defects, antiretroviral toxicity and cardiomyopathy.
Kohler JJ; Hosseini SH; Green E; Hoying-Brandt A; Cucoranu I; Haase CP; Russ R; Srivastava J; Ivey K; Ludaway T; Kapoor V; Abuin A; Shapoval A; Santoianni R; Saada A; Elpeleg O; Lewis W
Cardiovasc Toxicol; 2008; 8(2):57-69. PubMed ID: 18446447
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
[TBL] [Abstract][Full Text] [Related]
19. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
[TBL] [Abstract][Full Text] [Related]
20. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.
Tyynismaa H; Sun R; Ahola-Erkkilä S; Almusa H; Pöyhönen R; Korpela M; Honkaniemi J; Isohanni P; Paetau A; Wang L; Suomalainen A
Hum Mol Genet; 2012 Jan; 21(1):66-75. PubMed ID: 21937588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
